IL13RA2 and adrenal cortex carcinoma: One trial has been completed to date of the vaccine EO2401, which includes microbiome-derived peptides with molecular mimicry to 3 tumor-associated antigens known to be upregulated in ACC: IL13RA2, BIRC5, and FOXM1.